Study on absolute eosinophil count correlation with severity of bronchial asthma
DOI:
https://doi.org/10.18203/2320-6012.ijrms20191330Keywords:
Absolute eosinophil count, Bronchial asthma, FEV1%Abstract
Background: Bronchial asthma is defined as chronic inflammatory disease of the airways that is characterized by increased responsiveness of the tracheobronchial tree to a multiplicity of stimuli. Eosinophil infiltration is a characteristic feature of asthmatic airways. It presents as an obstructive type of ventilator defect usually diagnosed from a reduced FEV1% (Forced Expiratory Volume) or from a reduced peak expiratory flow (PEF) associated with reduced airway caliber during expiration. Allergen inhalation results in a marked increase in activated eosinophils in the airways. Correlation between the degree of bronchial hyperresponsiveness (a cardinal feature of asthma) and peripheral blood eosinophilia has been observed in patients with dual response following allergen challenge.
Methods: The study comprises a total number of 50 bronchial asthma patients of both sexes (male and female) between the age groups of 13-65 years. Based on severity, asthma patients were classified into mild, moderate and severe asthmatics, assessed by FEV1% computerized Spirometry Helios model number 701, recorders and medicare system. Peripheral blood sample was collected from each patient for absolute eosinophil count, the count was done on the same day.
Results: The mean±SD absolute eosinophil count of 50 patients is 330±88.64 which is slightly above normal (300 cells/mm3). Author found that the mean±SD absolute eosinophil count of 405±83.16 in severe asthma patients is quite high, corresponding with a steep decline in the FEV1% 45.3±12.6.
Conclusions: Absolute eosinophil count and FEV1% are important indicators of bronchial asthma severity and can even be used to predict disease progression.
References
Fadden ER. Asthma. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser S, Jameson JL, eds. Harrison’s Principle of Internal Medicine. 16th ed. New York: Mc Graw Hill; 2005: 1508-1516.
Cotes JE, Chinn DJ, Miller MR. Lung function in Asthma, COPD, Emphysema and Diffuse lung fibrosis. In: Cotes JE, Chinn DJ and Miller MR, eds. Lung Function. 6th ed. Massachusetts: Blackwell Publishing; 2006: 545-548.
Boron WF. Mechanics of Respiration. In: Schmitt WR, Dudlick M, eds. Medical Physiology. Pennsylvania: Elsevier Saunders; 2003: 606-632.
Barnes PJ. Asthma. In: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL and Loscalzo J, eds. Harrison’s Principle of Internal Medicine. 18th ed. United states of America: Mc Graw Hill; 2012: 2102-2112.
Husain AN. The Lung. In: Kumar V, Abbas AK, Fausto N, Aster JC, eds. Pathologic Basis of Disease. 8th ed. Pennsylvania: Elsevier Saunders; 2010: 677-737.
Mathur SK, Busse WW. The biology of Asthma. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM and Pack AI, eds. Fishman’s Pulmonary Diseases and Disorders Vol 1. 4th ed. China: Mc Graw Hill; 2008: 815-835.
Taylor KJ, Luksza AR. Peripheral blood eosinophil counts and bronchial responsiveness. Thorax. 1987;42(6):452-6.
Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Euro Resp J. 2007;30(3):452-6.
Jatakanon A, Uasuf C, Maziak W, Lim SA, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Resp Crit Care Med. 1999;160(5):1532-9.
Hussain MM, Ansari AK. Ventilatory lung functions and absolute eosinphil count in adult asthmatics. Pak Armed Forces Med J. 1998;48(2):117-22.
Rytila P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Euro Resp J. 2000;16(5):824-30.
Roquet A, Hallden G, Ihre E, Hed J, Zetterström O. Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyper‐reactivity in patients with. Allergy. 1996;51(7):482-8.
